PFIZER NORVASC CONTINUES STRONG GROWTH WITH U.S. SALES OF $785 MIL., UP 51% FOR 1996: JAMA STUDY SAYS CALCIUM CHANNEL BLOCKERS "OVERUSED" IN ELDERLY MI SURVIVORS
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
